Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Infectious Disease
•
Pulmonology
•
Pulmonary Infections
•
Primary Care
What is your approach to duration of antibiotic therapy for treatment of a bacterial lung abscess?
Related Questions
How would you approach treatment of latent TB for patients who cannot tolerate rifamycins or isoniazid due to allergy, intolerance, or drug-drug interactions?
Would you use the pneumococcal conjugate-21 vaccine (Capvaxive) instead of the conjugate-20 (Prevnar-20) for routine vaccinations in immunosuppressed patients?
How do you manage resistant infections that persist after stopping antibiotic therapy in patients with non-CF bronchiectasis?
How long do you recommend that a patient wear a mask when resuming biologic infusions following a recent upper respiratory infection?
Do you treat non-albicans strains of Candida on sputum culture or BAL in patients who are immunosuppressed?
How would you treat a patient with psoriatic arthritis who developed disseminated histoplasmosis while on adalimumab and previously failed all non-biologic DMARDs?
What is your preferred laboratory test to assess treatment response or infection resolution in patients with bacterial pneumonia?
Would you start treatment for MAC in a patient with nodular bronchiectatic disease who has demonstrated radiographic progression but remains asymptomatic and smear-negative?
What is the interpretation of an IGRA with positive TB wells and negative nil and negative mitogen wells?
Is there any utility to trending Histoplasma serology titers to guide duration of therapy or treatment response for pulmonary histoplasmosis with negative urine antigen?
